Sinopharm Accord, a Subsidiary of SINOPHARM, Projects Up to 90% Increase in Last Year's Net Profit
Company Overview: Sinopharm Accord, a subsidiary of SINOPHARM, is experiencing significant growth, with a projected YoY increase in net profit attributable to shareholders for 2025 estimated between 64.20% and 89.11%.
Profit Expectations: The company's net profit, excluding non-recurring gains and losses, is expected to rise by approximately 71.38% to 98.91% YoY, reaching between RMB996 million and RMB1.156 billion.
Earnings Per Share: Basic earnings per share are anticipated to increase to around RMB1.9-2.18, compared to RMB1.15 in the previous year.
Market Activity: The stock has seen short selling activity amounting to $20.10 million, with a short selling ratio of 23.277%.
Trade with 70% Backtested Accuracy
Analyst Views on 01099
About the author
<Daily Summary> HSI Ends at 26,765, Gaining 175 Points; HSTI Finishes at 5,260, Dropping 10 Points; HAIDILAO Surges Over 6%; HSBC HOLDINGS, TINGYI, SINOPHARM, TIME INTERCON, and WANGUO GOLD GP Reach New Peaks; Market Turnover Increases
Market Performance: The Hang Seng Index (HSI) rose by 175 points (0.7%) to 26,765, while the Hang Seng Technology Index (HSTI) fell by 10 points (0.2%) to 5,260, and the Hang Seng China Enterprises Index (HSCEI) increased by 26 points (0.3%) to 9,034, with a total market turnover of $236.77 billion.
Active Heavyweights: Notable stock movements included PING AN (+1.9%), MEITUAN (+1.6%), and TENCENT (+0.5%), while XIAOMI (-0.4%) and HKEX (-0.3%) saw declines.
Significant Gainers: HAIDILAO surged by 6.2%, HSBC HOLDINGS rose by 5.5% to a new high, and LONGFOR increased by 4.6%, while XINYI SOLAR and WH GROUP experienced declines of 3.6% and 3.3%, respectively.
Noteworthy Stocks: RIMAG GROUP dropped significantly by 10.6%, while TIME INTERCON and WANGUO GOLD GP saw increases of 10.2% and 6.9%, respectively, with both hitting new highs.
Midday Update: HSI Ends at 26,789, Gaining 199 Points; HSTI Reaches 5,288, Up 17 Points; HAIDILAO Surges Over 5%; LI NING, SINOPHARM, CHINA RES MIXC, HENGAN INT'L, and MTR CORPORATION Achieve New Highs
Market Performance: The Hang Seng Index (HSI) rose by 199 points (0.8%) to 26,789, while the Hang Seng Tech Index (HSTI) and the Hang Seng China Enterprises Index (HSCEI) also saw gains of 17 points (0.3%) and 81 points (0.9%) respectively.
Active Heavyweights: Notable stocks included Meituan, Ping An, Tencent, and Alibaba, all experiencing increases in their share prices, with Meituan leading at a 2.3% rise.
Top Gainers: Among HSI and HSCEI constituents, Haidilao and Longfor showed significant gains of 5.8% and 4.6% respectively, while Xinyi Solar was the only notable loser, dropping by 3.0%.
Short Selling Activity: High short selling ratios were observed in several stocks, with Ping An and China Resources Land having ratios of 35.649% and 40.187% respectively, indicating significant market speculation.
<Full-day Summary> HSI Falls by 491 Points; HSTI Declines by 114 Points; MEITUAN, PING AN Drop Over 4%; TENCENT Decreases Over 3%; WH GROUP, HENDERSON LAND, CKI HOLDINGS, MTR CORPORATION, SINOPHARM Reach New Peaks; Market Turnover Increases
Market Performance: The Hang Seng Index (HSI) fell by 491 points (1.8%) to close at 26,590, with significant declines also seen in the HSTI and HSCEI, which dropped 114 points (2.1%) and 189 points (2.1%) respectively, amid a market turnover of $250.99 billion.
Active Heavyweights: Major stocks like Meituan, Ping An, Tencent, Alibaba, and Xiaomi experienced notable declines, with Meituan down 4.2% and Tencent down 3.3%, reflecting a trend of short selling across these companies.
Constituents on the Move: Several constituents saw significant price changes, including Sino Biopharma and Hansoh Pharma, which dropped 6.6% and 6.4% respectively, while WH Group rose by 4.4%, reaching a new high.
Other Notable Stocks: Stocks such as MIRXES-B and CTG Duty-Free faced substantial losses, with MIRXES-B down 21.7%, while KB Laminates and CNBM saw gains of 12.4% and 10.5%, respectively, also hitting new highs.
<Midday Update> HSI Falls 523 Points; HSTI Declines 127 Points; MEITUAN, PING AN Drop Over 4%; TENCENT Decreases Over 3%; WH GROUP, HENDERSON LAND, CKI HOLDINGS, SINOPHARM, KB LAMINATES Reach New Peaks
Market Performance: The Hang Seng Index (HSI) fell by 523 points (1.9%) to 26,558, while the Hang Seng Tech Index (HSTI) and the Hang Seng China Enterprises Index (HSCEI) also experienced declines of 2.4% and 2.1%, respectively.
Active Heavyweights: Major stocks like Meituan, Ping An, Tencent, and Alibaba saw significant drops, with Meituan down 4.8% and Tencent down 3.4%, amidst high short selling ratios.
Notable Declines in Constituents: Several constituents, including Hansoh Pharma and Sino Biopharma, reported steep declines, with Hansoh Pharma down 6.5% and Sino Biopharma down 6.1%.
Gainers Amidst Losses: Despite the overall market downturn, a few stocks like WH Group and Henderson Land recorded gains, with WH Group up 3.2% and Henderson Land up 1.7%, both hitting new highs.
HSI Declines by 48 Points as BABA-W and BIDU-SW Fall; COSCO SHIP ENGY Rises Over 6%
Market Opening: The Hong Kong equity market opened lower after the Lunar New Year holiday, with the HSI down 0.2% at 26,657, the HSCEI down 0.2% at 9,052, and the HSTECH down 0.7% at 5,330.
Stock Performances: CNOOC and COSCO SHIP ENGY saw gains of 2.2% and 6.1% respectively, while tech stocks like BABA-W and BIDU-SW experienced declines of 3.7% and 5.2%.
Sector Movements: Commodities stocks generally rose, with notable increases from MMG and CMOC, while several automakers and financial stocks showed mixed results, with HSBC and HKEX slightly up.
Short Selling Trends: Significant short selling was observed across various sectors, particularly in tech stocks, with BILIBILI-W and KINGDEE INT'L experiencing notable declines alongside high short selling ratios.
UOB Kay Hian Supports ALI HEALTH and PA GOODDOCTOR as AI Innovations and National Policies Propel China's Internet Healthcare Industry
Chinese Internet Healthcare Sector Growth: The sector is evolving with increased AI innovation from tech giants and support from national policies, such as Beijing's online consultation pilot program, despite profitability challenges.
Stock Recommendations: UOB Kay Hian maintains a positive outlook on companies like ALI HEALTH and PA GOODDOCTOR, projecting significant revenue growth driven by AI and synergies with major partners.
Top Picks in Healthcare: UOB Kay Hian's top stock picks include BEONE MEDICINES, INNOVENT BIO, and HANSOH PHARMA, highlighting their potential for growth in the Chinese healthcare market.
Investment Ratings: Various companies in the sector have received investment ratings, with several being rated as "Buy," indicating strong confidence in their future performance.
<Daily Summary> HSI Ends at 26,765, Gaining 175 Points; HSTI Finishes at 5,260, Dropping 10 Points; HAIDILAO Surges Over 6%; HSBC HOLDINGS, TINGYI, SINOPHARM, TIME INTERCON, and WANGUO GOLD GP Reach New Peaks; Market Turnover Increases
Market Performance: The Hang Seng Index (HSI) rose by 175 points (0.7%) to 26,765, while the Hang Seng Technology Index (HSTI) fell by 10 points (0.2%) to 5,260, and the Hang Seng China Enterprises Index (HSCEI) increased by 26 points (0.3%) to 9,034, with a total market turnover of $236.77 billion.
Active Heavyweights: Notable stock movements included PING AN (+1.9%), MEITUAN (+1.6%), and TENCENT (+0.5%), while XIAOMI (-0.4%) and HKEX (-0.3%) saw declines.
Significant Gainers: HAIDILAO surged by 6.2%, HSBC HOLDINGS rose by 5.5% to a new high, and LONGFOR increased by 4.6%, while XINYI SOLAR and WH GROUP experienced declines of 3.6% and 3.3%, respectively.
Noteworthy Stocks: RIMAG GROUP dropped significantly by 10.6%, while TIME INTERCON and WANGUO GOLD GP saw increases of 10.2% and 6.9%, respectively, with both hitting new highs.
Midday Update: HSI Ends at 26,789, Gaining 199 Points; HSTI Reaches 5,288, Up 17 Points; HAIDILAO Surges Over 5%; LI NING, SINOPHARM, CHINA RES MIXC, HENGAN INT'L, and MTR CORPORATION Achieve New Highs
Market Performance: The Hang Seng Index (HSI) rose by 199 points (0.8%) to 26,789, while the Hang Seng Tech Index (HSTI) and the Hang Seng China Enterprises Index (HSCEI) also saw gains of 17 points (0.3%) and 81 points (0.9%) respectively.
Active Heavyweights: Notable stocks included Meituan, Ping An, Tencent, and Alibaba, all experiencing increases in their share prices, with Meituan leading at a 2.3% rise.
Top Gainers: Among HSI and HSCEI constituents, Haidilao and Longfor showed significant gains of 5.8% and 4.6% respectively, while Xinyi Solar was the only notable loser, dropping by 3.0%.
Short Selling Activity: High short selling ratios were observed in several stocks, with Ping An and China Resources Land having ratios of 35.649% and 40.187% respectively, indicating significant market speculation.
<Full-day Summary> HSI Falls by 491 Points; HSTI Declines by 114 Points; MEITUAN, PING AN Drop Over 4%; TENCENT Decreases Over 3%; WH GROUP, HENDERSON LAND, CKI HOLDINGS, MTR CORPORATION, SINOPHARM Reach New Peaks; Market Turnover Increases
Market Performance: The Hang Seng Index (HSI) fell by 491 points (1.8%) to close at 26,590, with significant declines also seen in the HSTI and HSCEI, which dropped 114 points (2.1%) and 189 points (2.1%) respectively, amid a market turnover of $250.99 billion.
Active Heavyweights: Major stocks like Meituan, Ping An, Tencent, Alibaba, and Xiaomi experienced notable declines, with Meituan down 4.2% and Tencent down 3.3%, reflecting a trend of short selling across these companies.
Constituents on the Move: Several constituents saw significant price changes, including Sino Biopharma and Hansoh Pharma, which dropped 6.6% and 6.4% respectively, while WH Group rose by 4.4%, reaching a new high.
Other Notable Stocks: Stocks such as MIRXES-B and CTG Duty-Free faced substantial losses, with MIRXES-B down 21.7%, while KB Laminates and CNBM saw gains of 12.4% and 10.5%, respectively, also hitting new highs.
<Midday Update> HSI Falls 523 Points; HSTI Declines 127 Points; MEITUAN, PING AN Drop Over 4%; TENCENT Decreases Over 3%; WH GROUP, HENDERSON LAND, CKI HOLDINGS, SINOPHARM, KB LAMINATES Reach New Peaks
Market Performance: The Hang Seng Index (HSI) fell by 523 points (1.9%) to 26,558, while the Hang Seng Tech Index (HSTI) and the Hang Seng China Enterprises Index (HSCEI) also experienced declines of 2.4% and 2.1%, respectively.
Active Heavyweights: Major stocks like Meituan, Ping An, Tencent, and Alibaba saw significant drops, with Meituan down 4.8% and Tencent down 3.4%, amidst high short selling ratios.
Notable Declines in Constituents: Several constituents, including Hansoh Pharma and Sino Biopharma, reported steep declines, with Hansoh Pharma down 6.5% and Sino Biopharma down 6.1%.
Gainers Amidst Losses: Despite the overall market downturn, a few stocks like WH Group and Henderson Land recorded gains, with WH Group up 3.2% and Henderson Land up 1.7%, both hitting new highs.
HSI Declines by 48 Points as BABA-W and BIDU-SW Fall; COSCO SHIP ENGY Rises Over 6%
Market Opening: The Hong Kong equity market opened lower after the Lunar New Year holiday, with the HSI down 0.2% at 26,657, the HSCEI down 0.2% at 9,052, and the HSTECH down 0.7% at 5,330.
Stock Performances: CNOOC and COSCO SHIP ENGY saw gains of 2.2% and 6.1% respectively, while tech stocks like BABA-W and BIDU-SW experienced declines of 3.7% and 5.2%.
Sector Movements: Commodities stocks generally rose, with notable increases from MMG and CMOC, while several automakers and financial stocks showed mixed results, with HSBC and HKEX slightly up.
Short Selling Trends: Significant short selling was observed across various sectors, particularly in tech stocks, with BILIBILI-W and KINGDEE INT'L experiencing notable declines alongside high short selling ratios.
UOB Kay Hian Supports ALI HEALTH and PA GOODDOCTOR as AI Innovations and National Policies Propel China's Internet Healthcare Industry
Chinese Internet Healthcare Sector Growth: The sector is evolving with increased AI innovation from tech giants and support from national policies, such as Beijing's online consultation pilot program, despite profitability challenges.
Stock Recommendations: UOB Kay Hian maintains a positive outlook on companies like ALI HEALTH and PA GOODDOCTOR, projecting significant revenue growth driven by AI and synergies with major partners.
Top Picks in Healthcare: UOB Kay Hian's top stock picks include BEONE MEDICINES, INNOVENT BIO, and HANSOH PHARMA, highlighting their potential for growth in the Chinese healthcare market.
Investment Ratings: Various companies in the sector have received investment ratings, with several being rated as "Buy," indicating strong confidence in their future performance.
